nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A5—dilated cardiomyopathy	0.49	1	CbGaD
Valproic Acid—SLC22A5—Furosemide—dilated cardiomyopathy	0.0874	0.341	CbGbCtD
Valproic Acid—SLC22A8—Furosemide—dilated cardiomyopathy	0.0715	0.279	CbGbCtD
Valproic Acid—SLC22A6—Furosemide—dilated cardiomyopathy	0.0498	0.194	CbGbCtD
Valproic Acid—CYP2C8—Spironolactone—dilated cardiomyopathy	0.048	0.187	CbGbCtD
Valproic Acid—CYP2C9—cardial valve—dilated cardiomyopathy	0.00773	0.152	CbGeAlD
Valproic Acid—OGDH—cardiac ventricle—dilated cardiomyopathy	0.00331	0.0651	CbGeAlD
Valproic Acid—OGDH—myocardium—dilated cardiomyopathy	0.00311	0.0612	CbGeAlD
Valproic Acid—HDAC9—myocardium—dilated cardiomyopathy	0.00274	0.0539	CbGeAlD
Valproic Acid—ACADSB—cardiac ventricle—dilated cardiomyopathy	0.00263	0.0517	CbGeAlD
Valproic Acid—ACADSB—myocardium—dilated cardiomyopathy	0.00247	0.0486	CbGeAlD
Valproic Acid—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00246	0.0202	CcSEcCtD
Valproic Acid—Incontinence—Furosemide—dilated cardiomyopathy	0.00235	0.0193	CcSEcCtD
Valproic Acid—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00233	0.0191	CcSEcCtD
Valproic Acid—ALDH5A1—cardiac ventricle—dilated cardiomyopathy	0.00231	0.0455	CbGeAlD
Valproic Acid—ALDH5A1—myocardium—dilated cardiomyopathy	0.00218	0.0428	CbGeAlD
Valproic Acid—OGDH—heart—dilated cardiomyopathy	0.00217	0.0427	CbGeAlD
Valproic Acid—HDAC9—heart—dilated cardiomyopathy	0.00191	0.0377	CbGeAlD
Valproic Acid—OGDH—cardiac atrium—dilated cardiomyopathy	0.00186	0.0365	CbGeAlD
Valproic Acid—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00178	0.0146	CcSEcCtD
Valproic Acid—ACADSB—heart—dilated cardiomyopathy	0.00173	0.0339	CbGeAlD
Valproic Acid—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00172	0.0141	CcSEcCtD
Valproic Acid—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00155	0.0127	CcSEcCtD
Valproic Acid—ALDH5A1—heart—dilated cardiomyopathy	0.00152	0.0299	CbGeAlD
Valproic Acid—ACADSB—cardiac atrium—dilated cardiomyopathy	0.00148	0.029	CbGeAlD
Valproic Acid—HDAC2—myocardium—dilated cardiomyopathy	0.0014	0.0276	CbGeAlD
Valproic Acid—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00139	0.0114	CcSEcCtD
Valproic Acid—Drug eruption—Furosemide—dilated cardiomyopathy	0.00134	0.011	CcSEcCtD
Valproic Acid—SLC16A1—cardiac ventricle—dilated cardiomyopathy	0.00132	0.0261	CbGeAlD
Valproic Acid—ABAT—heart—dilated cardiomyopathy	0.0013	0.0256	CbGeAlD
Valproic Acid—ALDH5A1—cardiac atrium—dilated cardiomyopathy	0.0013	0.0255	CbGeAlD
Valproic Acid—SLC16A1—myocardium—dilated cardiomyopathy	0.00125	0.0245	CbGeAlD
Valproic Acid—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00939	CcSEcCtD
Valproic Acid—Blister—Furosemide—dilated cardiomyopathy	0.00114	0.00937	CcSEcCtD
Valproic Acid—Lethargy—Spironolactone—dilated cardiomyopathy	0.00112	0.00919	CcSEcCtD
Valproic Acid—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0011	0.00904	CcSEcCtD
Valproic Acid—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00106	0.00872	CcSEcCtD
Valproic Acid—Ataxia—Spironolactone—dilated cardiomyopathy	0.00103	0.00847	CcSEcCtD
Valproic Acid—Injection site pain—Furosemide—dilated cardiomyopathy	0.00101	0.00827	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000988	0.00811	CcSEcCtD
Valproic Acid—HDAC2—heart—dilated cardiomyopathy	0.000979	0.0192	CbGeAlD
Valproic Acid—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00095	0.00779	CcSEcCtD
Valproic Acid—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000939	0.00771	CcSEcCtD
Valproic Acid—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.000914	0.00751	CcSEcCtD
Valproic Acid—Drug interaction—Furosemide—dilated cardiomyopathy	0.000887	0.00728	CcSEcCtD
Valproic Acid—SLC16A1—heart—dilated cardiomyopathy	0.00087	0.0171	CbGeAlD
Valproic Acid—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000864	0.00709	CcSEcCtD
Valproic Acid—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000864	0.00709	CcSEcCtD
Valproic Acid—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000846	0.00694	CcSEcCtD
Valproic Acid—Vasculitis—Furosemide—dilated cardiomyopathy	0.000843	0.00692	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000839	0.00688	CcSEcCtD
Valproic Acid—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000806	0.00662	CcSEcCtD
Valproic Acid—Otitis media—Lisinopril—dilated cardiomyopathy	0.000793	0.00651	CcSEcCtD
Valproic Acid—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000789	0.00648	CcSEcCtD
Valproic Acid—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000786	0.00646	CcSEcCtD
Valproic Acid—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000772	0.00634	CcSEcCtD
Valproic Acid—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000757	0.0149	CbGeAlD
Valproic Acid—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000756	0.0062	CcSEcCtD
Valproic Acid—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000745	0.00611	CcSEcCtD
Valproic Acid—SLC16A1—cardiac atrium—dilated cardiomyopathy	0.000744	0.0146	CbGeAlD
Valproic Acid—Bladder pain—Furosemide—dilated cardiomyopathy	0.000744	0.00611	CcSEcCtD
Valproic Acid—Urine output increased—Furosemide—dilated cardiomyopathy	0.000744	0.00611	CcSEcCtD
Valproic Acid—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000718	0.00589	CcSEcCtD
Valproic Acid—Mental disability—Furosemide—dilated cardiomyopathy	0.000714	0.00586	CcSEcCtD
Valproic Acid—SLC22A5—myocardium—dilated cardiomyopathy	0.000712	0.014	CbGeAlD
Valproic Acid—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000698	0.00573	CcSEcCtD
Valproic Acid—Viral infection—Lisinopril—dilated cardiomyopathy	0.000683	0.00561	CcSEcCtD
Valproic Acid—Polyuria—Furosemide—dilated cardiomyopathy	0.00068	0.00558	CcSEcCtD
Valproic Acid—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00068	0.00558	CcSEcCtD
Valproic Acid—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000679	0.00557	CcSEcCtD
Valproic Acid—Swelling—Furosemide—dilated cardiomyopathy	0.000677	0.00556	CcSEcCtD
Valproic Acid—Cough increased—Lisinopril—dilated cardiomyopathy	0.000674	0.00553	CcSEcCtD
Valproic Acid—Alopecia—Spironolactone—dilated cardiomyopathy	0.000671	0.00551	CcSEcCtD
Valproic Acid—Deafness—Furosemide—dilated cardiomyopathy	0.000668	0.00548	CcSEcCtD
Valproic Acid—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000665	0.00546	CcSEcCtD
Valproic Acid—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000636	0.00522	CcSEcCtD
Valproic Acid—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000632	0.00519	CcSEcCtD
Valproic Acid—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000625	0.00513	CcSEcCtD
Valproic Acid—Neck pain—Lisinopril—dilated cardiomyopathy	0.000625	0.00513	CcSEcCtD
Valproic Acid—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000613	0.00503	CcSEcCtD
Valproic Acid—Lethargy—Furosemide—dilated cardiomyopathy	0.000609	0.005	CcSEcCtD
Valproic Acid—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000603	0.00495	CcSEcCtD
Valproic Acid—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0006	0.00492	CcSEcCtD
Valproic Acid—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.0006	0.00492	CcSEcCtD
Valproic Acid—Malaise—Spironolactone—dilated cardiomyopathy	0.000596	0.00489	CcSEcCtD
Valproic Acid—Cystitis—Lisinopril—dilated cardiomyopathy	0.000596	0.00489	CcSEcCtD
Valproic Acid—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000592	0.00486	CcSEcCtD
Valproic Acid—Photophobia—Lisinopril—dilated cardiomyopathy	0.00058	0.00476	CcSEcCtD
Valproic Acid—PTGS1—myocardium—dilated cardiomyopathy	0.000559	0.011	CbGeAlD
Valproic Acid—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000558	0.00458	CcSEcCtD
Valproic Acid—Discomfort—Spironolactone—dilated cardiomyopathy	0.000556	0.00456	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000545	0.00448	CcSEcCtD
Valproic Acid—Confusional state—Spironolactone—dilated cardiomyopathy	0.000544	0.00446	CcSEcCtD
Valproic Acid—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000541	0.00444	CcSEcCtD
Valproic Acid—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00054	0.00443	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000538	0.00441	CcSEcCtD
Valproic Acid—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000528	0.00434	CcSEcCtD
Valproic Acid—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000527	0.00432	CcSEcCtD
Valproic Acid—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000518	0.00425	CcSEcCtD
Valproic Acid—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000513	0.00421	CcSEcCtD
Valproic Acid—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000511	0.00419	CcSEcCtD
Valproic Acid—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00051	0.00419	CcSEcCtD
Valproic Acid—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000506	0.00415	CcSEcCtD
Valproic Acid—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000506	0.00415	CcSEcCtD
Valproic Acid—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000499	0.00409	CcSEcCtD
Valproic Acid—SLC22A5—heart—dilated cardiomyopathy	0.000497	0.00977	CbGeAlD
Valproic Acid—Injury—Lisinopril—dilated cardiomyopathy	0.000488	0.004	CcSEcCtD
Valproic Acid—Somnolence—Spironolactone—dilated cardiomyopathy	0.00048	0.00394	CcSEcCtD
Valproic Acid—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000477	0.00391	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000471	0.00387	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000466	0.00382	CcSEcCtD
Valproic Acid—Drowsiness—Furosemide—dilated cardiomyopathy	0.00046	0.00378	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000456	0.00374	CcSEcCtD
Valproic Acid—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00045	0.00369	CcSEcCtD
Valproic Acid—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000448	0.00368	CcSEcCtD
Valproic Acid—Diplopia—Lisinopril—dilated cardiomyopathy	0.000448	0.00368	CcSEcCtD
Valproic Acid—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000445	0.00365	CcSEcCtD
Valproic Acid—Sweating—Furosemide—dilated cardiomyopathy	0.000441	0.00362	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000435	0.00357	CcSEcCtD
Valproic Acid—Face oedema—Lisinopril—dilated cardiomyopathy	0.000433	0.00355	CcSEcCtD
Valproic Acid—CYP2B6—heart—dilated cardiomyopathy	0.000432	0.00849	CbGeAlD
Valproic Acid—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000429	0.00353	CcSEcCtD
Valproic Acid—Urticaria—Spironolactone—dilated cardiomyopathy	0.000429	0.00352	CcSEcCtD
Valproic Acid—CYP2C9—heart—dilated cardiomyopathy	0.000427	0.0084	CbGeAlD
Valproic Acid—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000427	0.0035	CcSEcCtD
Valproic Acid—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000425	0.00836	CbGeAlD
Valproic Acid—Ataxia—Lisinopril—dilated cardiomyopathy	0.000421	0.00346	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000409	0.00336	CcSEcCtD
Valproic Acid—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000408	0.00335	CcSEcCtD
Valproic Acid—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000405	0.00332	CcSEcCtD
Valproic Acid—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000405	0.00332	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000404	0.00331	CcSEcCtD
Valproic Acid—Visual impairment—Furosemide—dilated cardiomyopathy	0.000398	0.00327	CcSEcCtD
Valproic Acid—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000398	0.00326	CcSEcCtD
Valproic Acid—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000391	0.00321	CcSEcCtD
Valproic Acid—PTGS1—heart—dilated cardiomyopathy	0.00039	0.00767	CbGeAlD
Valproic Acid—Influenza—Lisinopril—dilated cardiomyopathy	0.000387	0.00318	CcSEcCtD
Valproic Acid—Eye disorder—Furosemide—dilated cardiomyopathy	0.000386	0.00317	CcSEcCtD
Valproic Acid—Tinnitus—Furosemide—dilated cardiomyopathy	0.000385	0.00316	CcSEcCtD
Valproic Acid—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000383	0.00315	CcSEcCtD
Valproic Acid—Pruritus—Spironolactone—dilated cardiomyopathy	0.000382	0.00313	CcSEcCtD
Valproic Acid—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00038	0.00312	CcSEcCtD
Valproic Acid—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000377	0.0031	CcSEcCtD
Valproic Acid—Angiopathy—Furosemide—dilated cardiomyopathy	0.000375	0.00308	CcSEcCtD
Valproic Acid—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000373	0.00306	CcSEcCtD
Valproic Acid—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000372	0.00306	CcSEcCtD
Valproic Acid—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000369	0.00303	CcSEcCtD
Valproic Acid—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000369	0.00303	CcSEcCtD
Valproic Acid—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000368	0.00302	CcSEcCtD
Valproic Acid—Dysuria—Lisinopril—dilated cardiomyopathy	0.000362	0.00297	CcSEcCtD
Valproic Acid—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000362	0.00297	CcSEcCtD
Valproic Acid—Malnutrition—Furosemide—dilated cardiomyopathy	0.00036	0.00295	CcSEcCtD
Valproic Acid—Dizziness—Spironolactone—dilated cardiomyopathy	0.000357	0.00293	CcSEcCtD
Valproic Acid—Flatulence—Furosemide—dilated cardiomyopathy	0.000354	0.00291	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000354	0.0029	CcSEcCtD
Valproic Acid—Weight increased—Lisinopril—dilated cardiomyopathy	0.000352	0.00289	CcSEcCtD
Valproic Acid—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000352	0.00289	CcSEcCtD
Valproic Acid—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00035	0.00288	CcSEcCtD
Valproic Acid—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000347	0.00285	CcSEcCtD
Valproic Acid—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000346	0.00284	CcSEcCtD
Valproic Acid—Depression—Lisinopril—dilated cardiomyopathy	0.000344	0.00283	CcSEcCtD
Valproic Acid—Vomiting—Spironolactone—dilated cardiomyopathy	0.000343	0.00282	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000342	0.00281	CcSEcCtD
Valproic Acid—Rash—Spironolactone—dilated cardiomyopathy	0.00034	0.00279	CcSEcCtD
Valproic Acid—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00034	0.00279	CcSEcCtD
Valproic Acid—Vision blurred—Furosemide—dilated cardiomyopathy	0.000339	0.00278	CcSEcCtD
Valproic Acid—Headache—Spironolactone—dilated cardiomyopathy	0.000338	0.00277	CcSEcCtD
Valproic Acid—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000336	0.00275	CcSEcCtD
Valproic Acid—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000334	0.00656	CbGeAlD
Valproic Acid—Anaemia—Furosemide—dilated cardiomyopathy	0.000332	0.00273	CcSEcCtD
Valproic Acid—Sweating—Lisinopril—dilated cardiomyopathy	0.000331	0.00272	CcSEcCtD
Valproic Acid—Agitation—Furosemide—dilated cardiomyopathy	0.000331	0.00271	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000327	0.00268	CcSEcCtD
Valproic Acid—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000326	0.00267	CcSEcCtD
Valproic Acid—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000324	0.00266	CcSEcCtD
Valproic Acid—Vertigo—Furosemide—dilated cardiomyopathy	0.000323	0.00265	CcSEcCtD
Valproic Acid—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000322	0.00264	CcSEcCtD
Valproic Acid—Leukopenia—Furosemide—dilated cardiomyopathy	0.000322	0.00264	CcSEcCtD
Valproic Acid—Nausea—Spironolactone—dilated cardiomyopathy	0.00032	0.00263	CcSEcCtD
Valproic Acid—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000316	0.00259	CcSEcCtD
Valproic Acid—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000311	0.00255	CcSEcCtD
Valproic Acid—Hallucination—Lisinopril—dilated cardiomyopathy	0.000308	0.00253	CcSEcCtD
Valproic Acid—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000308	0.00253	CcSEcCtD
Valproic Acid—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000306	0.00251	CcSEcCtD
Valproic Acid—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000305	0.00251	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000304	0.0025	CcSEcCtD
Valproic Acid—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000304	0.00249	CcSEcCtD
Valproic Acid—Dry mouth—Furosemide—dilated cardiomyopathy	0.000299	0.00246	CcSEcCtD
Valproic Acid—Confusional state—Furosemide—dilated cardiomyopathy	0.000296	0.00243	CcSEcCtD
Valproic Acid—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000294	0.00241	CcSEcCtD
Valproic Acid—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000293	0.00241	CcSEcCtD
Valproic Acid—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000289	0.00237	CcSEcCtD
Valproic Acid—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000288	0.00236	CcSEcCtD
Valproic Acid—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000287	0.00236	CcSEcCtD
Valproic Acid—Skin disorder—Furosemide—dilated cardiomyopathy	0.000285	0.00234	CcSEcCtD
Valproic Acid—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000284	0.00233	CcSEcCtD
Valproic Acid—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000281	0.00231	CcSEcCtD
Valproic Acid—Anorexia—Furosemide—dilated cardiomyopathy	0.00028	0.0023	CcSEcCtD
Valproic Acid—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000279	0.00229	CcSEcCtD
Valproic Acid—Chills—Lisinopril—dilated cardiomyopathy	0.000278	0.00228	CcSEcCtD
Valproic Acid—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000277	0.00227	CcSEcCtD
Valproic Acid—Hypotension—Furosemide—dilated cardiomyopathy	0.000274	0.00225	CcSEcCtD
Valproic Acid—Alopecia—Lisinopril—dilated cardiomyopathy	0.000274	0.00225	CcSEcCtD
Valproic Acid—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000272	0.00223	CcSEcCtD
Valproic Acid—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00027	0.00221	CcSEcCtD
Valproic Acid—Flatulence—Lisinopril—dilated cardiomyopathy	0.000266	0.00218	CcSEcCtD
Valproic Acid—Tension—Lisinopril—dilated cardiomyopathy	0.000265	0.00217	CcSEcCtD
Valproic Acid—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000264	0.00217	CcSEcCtD
Valproic Acid—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000264	0.00216	CcSEcCtD
Valproic Acid—Nervousness—Lisinopril—dilated cardiomyopathy	0.000262	0.00215	CcSEcCtD
Valproic Acid—Back pain—Lisinopril—dilated cardiomyopathy	0.000261	0.00214	CcSEcCtD
Valproic Acid—Somnolence—Furosemide—dilated cardiomyopathy	0.000261	0.00214	CcSEcCtD
Valproic Acid—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000259	0.00213	CcSEcCtD
Valproic Acid—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000255	0.00209	CcSEcCtD
Valproic Acid—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000254	0.00209	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000253	0.00208	CcSEcCtD
Valproic Acid—Fatigue—Furosemide—dilated cardiomyopathy	0.000253	0.00208	CcSEcCtD
Valproic Acid—Tremor—Lisinopril—dilated cardiomyopathy	0.000253	0.00208	CcSEcCtD
Valproic Acid—Constipation—Furosemide—dilated cardiomyopathy	0.000251	0.00206	CcSEcCtD
Valproic Acid—Pain—Furosemide—dilated cardiomyopathy	0.000251	0.00206	CcSEcCtD
Valproic Acid—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00025	0.00205	CcSEcCtD
Valproic Acid—Anaemia—Lisinopril—dilated cardiomyopathy	0.000249	0.00205	CcSEcCtD
Valproic Acid—Angioedema—Lisinopril—dilated cardiomyopathy	0.000247	0.00202	CcSEcCtD
Valproic Acid—Malaise—Lisinopril—dilated cardiomyopathy	0.000243	0.002	CcSEcCtD
Valproic Acid—Vertigo—Lisinopril—dilated cardiomyopathy	0.000242	0.00199	CcSEcCtD
Valproic Acid—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000242	0.00199	CcSEcCtD
Valproic Acid—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000242	0.00198	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00024	0.00197	CcSEcCtD
Valproic Acid—Palpitations—Lisinopril—dilated cardiomyopathy	0.000238	0.00196	CcSEcCtD
Valproic Acid—Cough—Lisinopril—dilated cardiomyopathy	0.000235	0.00193	CcSEcCtD
Valproic Acid—Urticaria—Furosemide—dilated cardiomyopathy	0.000233	0.00191	CcSEcCtD
Valproic Acid—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000232	0.0019	CcSEcCtD
Valproic Acid—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000232	0.0019	CcSEcCtD
Valproic Acid—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00023	0.00189	CcSEcCtD
Valproic Acid—Chest pain—Lisinopril—dilated cardiomyopathy	0.00023	0.00189	CcSEcCtD
Valproic Acid—Myalgia—Lisinopril—dilated cardiomyopathy	0.00023	0.00189	CcSEcCtD
Valproic Acid—Anxiety—Lisinopril—dilated cardiomyopathy	0.000229	0.00188	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000228	0.00187	CcSEcCtD
Valproic Acid—Discomfort—Lisinopril—dilated cardiomyopathy	0.000227	0.00186	CcSEcCtD
Valproic Acid—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000225	0.00184	CcSEcCtD
Valproic Acid—Confusional state—Lisinopril—dilated cardiomyopathy	0.000222	0.00182	CcSEcCtD
Valproic Acid—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00022	0.00181	CcSEcCtD
Valproic Acid—Oedema—Lisinopril—dilated cardiomyopathy	0.00022	0.00181	CcSEcCtD
Valproic Acid—Infection—Lisinopril—dilated cardiomyopathy	0.000219	0.0018	CcSEcCtD
Valproic Acid—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000216	0.00177	CcSEcCtD
Valproic Acid—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000216	0.00177	CcSEcCtD
Valproic Acid—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000215	0.00176	CcSEcCtD
Valproic Acid—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000214	0.00176	CcSEcCtD
Valproic Acid—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000213	0.00175	CcSEcCtD
Valproic Acid—Asthenia—Furosemide—dilated cardiomyopathy	0.000211	0.00173	CcSEcCtD
Valproic Acid—Anorexia—Lisinopril—dilated cardiomyopathy	0.00021	0.00172	CcSEcCtD
Valproic Acid—Pruritus—Furosemide—dilated cardiomyopathy	0.000208	0.0017	CcSEcCtD
Valproic Acid—Hypotension—Lisinopril—dilated cardiomyopathy	0.000206	0.00169	CcSEcCtD
Valproic Acid—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000201	0.00165	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000201	0.00165	CcSEcCtD
Valproic Acid—Insomnia—Lisinopril—dilated cardiomyopathy	0.000199	0.00163	CcSEcCtD
Valproic Acid—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000198	0.00162	CcSEcCtD
Valproic Acid—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000196	0.00161	CcSEcCtD
Valproic Acid—Somnolence—Lisinopril—dilated cardiomyopathy	0.000196	0.00161	CcSEcCtD
Valproic Acid—Dizziness—Furosemide—dilated cardiomyopathy	0.000194	0.00159	CcSEcCtD
Valproic Acid—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000194	0.00159	CcSEcCtD
Valproic Acid—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000191	0.00157	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00019	0.00156	CcSEcCtD
Valproic Acid—Fatigue—Lisinopril—dilated cardiomyopathy	0.00019	0.00156	CcSEcCtD
Valproic Acid—Constipation—Lisinopril—dilated cardiomyopathy	0.000188	0.00155	CcSEcCtD
Valproic Acid—Pain—Lisinopril—dilated cardiomyopathy	0.000188	0.00155	CcSEcCtD
Valproic Acid—Vomiting—Furosemide—dilated cardiomyopathy	0.000187	0.00153	CcSEcCtD
Valproic Acid—Rash—Furosemide—dilated cardiomyopathy	0.000185	0.00152	CcSEcCtD
Valproic Acid—Dermatitis—Furosemide—dilated cardiomyopathy	0.000185	0.00152	CcSEcCtD
Valproic Acid—Headache—Furosemide—dilated cardiomyopathy	0.000184	0.00151	CcSEcCtD
Valproic Acid—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000181	0.00149	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00018	0.00148	CcSEcCtD
Valproic Acid—Urticaria—Lisinopril—dilated cardiomyopathy	0.000175	0.00144	CcSEcCtD
Valproic Acid—Nausea—Furosemide—dilated cardiomyopathy	0.000174	0.00143	CcSEcCtD
Valproic Acid—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000174	0.00143	CcSEcCtD
Valproic Acid—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000174	0.00143	CcSEcCtD
Valproic Acid—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000162	0.00133	CcSEcCtD
Valproic Acid—Asthenia—Lisinopril—dilated cardiomyopathy	0.000158	0.0013	CcSEcCtD
Valproic Acid—Pruritus—Lisinopril—dilated cardiomyopathy	0.000156	0.00128	CcSEcCtD
Valproic Acid—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000151	0.00124	CcSEcCtD
Valproic Acid—Dizziness—Lisinopril—dilated cardiomyopathy	0.000146	0.0012	CcSEcCtD
Valproic Acid—Vomiting—Lisinopril—dilated cardiomyopathy	0.00014	0.00115	CcSEcCtD
Valproic Acid—Rash—Lisinopril—dilated cardiomyopathy	0.000139	0.00114	CcSEcCtD
Valproic Acid—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000139	0.00114	CcSEcCtD
Valproic Acid—Headache—Lisinopril—dilated cardiomyopathy	0.000138	0.00113	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—TTN—dilated cardiomyopathy	0.000133	0.00165	CbGpPWpGaD
Valproic Acid—Nausea—Lisinopril—dilated cardiomyopathy	0.000131	0.00107	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—ACTN2—dilated cardiomyopathy	0.000126	0.00157	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000126	0.00156	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000125	0.00155	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.000124	0.00154	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—SDHA—dilated cardiomyopathy	0.000122	0.00152	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000122	0.00152	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000122	0.00152	CbGpPWpGaD
Valproic Acid—ALDH5A1—Neuronal System—RAF1—dilated cardiomyopathy	0.000121	0.00151	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—GPX1—dilated cardiomyopathy	0.00012	0.0015	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.00012	0.00149	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00012	0.00149	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00012	0.00149	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000119	0.00148	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000116	0.00145	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ACTN2—dilated cardiomyopathy	0.000115	0.00143	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000114	0.00141	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000113	0.00141	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000113	0.00141	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—RAC1—dilated cardiomyopathy	0.000113	0.00141	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—TAZ—dilated cardiomyopathy	0.000113	0.0014	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—FAS—dilated cardiomyopathy	0.000113	0.0014	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000112	0.0014	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000108	0.00134	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VCL—dilated cardiomyopathy	0.000107	0.00133	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000105	0.00131	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000105	0.00131	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000105	0.00131	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—SDHA—dilated cardiomyopathy	0.000102	0.00127	CbGpPWpGaD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000102	0.00127	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000101	0.00126	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0001	0.00125	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.0001	0.00125	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	9.81e-05	0.00122	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VCL—dilated cardiomyopathy	9.8e-05	0.00122	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.78e-05	0.00122	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.78e-05	0.00122	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.75e-05	0.00121	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.52e-05	0.00118	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.52e-05	0.00118	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.28e-05	0.00115	CbGpPWpGaD
Valproic Acid—ABAT—Neuronal System—RAF1—dilated cardiomyopathy	9.19e-05	0.00114	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.17e-05	0.00114	CbGpPWpGaD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.09e-05	0.00113	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—NPPA—dilated cardiomyopathy	9.06e-05	0.00113	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	9.02e-05	0.00112	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of Telomerase—EGFR—dilated cardiomyopathy	8.95e-05	0.00111	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.85e-05	0.0011	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	8.83e-05	0.0011	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PSEN2—dilated cardiomyopathy	8.78e-05	0.00109	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—TAZ—dilated cardiomyopathy	8.72e-05	0.00108	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	8.62e-05	0.00107	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—FAS—dilated cardiomyopathy	8.44e-05	0.00105	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	8.33e-05	0.00104	CbGpPWpGaD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	8.29e-05	0.00103	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ANKRD1—dilated cardiomyopathy	8.27e-05	0.00103	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	8.21e-05	0.00102	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.16e-05	0.00102	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.94e-05	0.000987	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.94e-05	0.000987	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SDHA—dilated cardiomyopathy	7.89e-05	0.000981	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—TAZ—dilated cardiomyopathy	7.77e-05	0.000966	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	7.71e-05	0.000959	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.38e-05	0.000918	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	7.37e-05	0.000916	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	7.25e-05	0.000901	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—GPX1—dilated cardiomyopathy	7.24e-05	0.0009	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.08e-05	0.00088	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—CD36—dilated cardiomyopathy	7.05e-05	0.000877	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SDHA—dilated cardiomyopathy	7.03e-05	0.000874	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	6.76e-05	0.00084	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NR3C2—dilated cardiomyopathy	6.74e-05	0.000838	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	6.74e-05	0.000838	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	6.56e-05	0.000815	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	6.56e-05	0.000815	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AGT—dilated cardiomyopathy	6.35e-05	0.000789	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	6.34e-05	0.000788	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.3e-05	0.000783	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—RAC1—dilated cardiomyopathy	6.24e-05	0.000776	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	6.16e-05	0.000766	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—GPX1—dilated cardiomyopathy	6.16e-05	0.000766	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.15e-05	0.000764	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	6.08e-05	0.000756	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CD36—dilated cardiomyopathy	6e-05	0.000746	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.92e-05	0.000736	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	5.73e-05	0.000713	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.62e-05	0.000699	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	5.57e-05	0.000693	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.46e-05	0.000679	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.46e-05	0.000679	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AGT—dilated cardiomyopathy	5.4e-05	0.000671	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—ITGB1—dilated cardiomyopathy	5.38e-05	0.000669	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	5.33e-05	0.000662	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.29e-05	0.000657	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.13e-05	0.000637	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.07e-05	0.000631	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—dilated cardiomyopathy	5.03e-05	0.000625	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	5.01e-05	0.000623	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ITGB1—dilated cardiomyopathy	4.92e-05	0.000612	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.91e-05	0.000611	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.82e-05	0.000599	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.61e-05	0.000573	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—CD36—dilated cardiomyopathy	4.59e-05	0.00057	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	4.53e-05	0.000563	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—RAC1—dilated cardiomyopathy	4.41e-05	0.000549	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.38e-05	0.000545	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	4.34e-05	0.00054	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—RAC1—dilated cardiomyopathy	4.32e-05	0.000537	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NPPA—dilated cardiomyopathy	4.23e-05	0.000526	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.2e-05	0.000522	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—CD36—dilated cardiomyopathy	4.2e-05	0.000522	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—RAF1—dilated cardiomyopathy	4.14e-05	0.000514	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.12e-05	0.000512	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	4.11e-05	0.000511	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	4.08e-05	0.000508	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.98e-05	0.000495	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.98e-05	0.000495	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—RAC1—dilated cardiomyopathy	3.95e-05	0.000492	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NPPA—dilated cardiomyopathy	3.93e-05	0.000489	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	3.86e-05	0.00048	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PSEN2—dilated cardiomyopathy	3.81e-05	0.000473	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GPX1—dilated cardiomyopathy	3.8e-05	0.000473	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CD36—dilated cardiomyopathy	3.7e-05	0.000461	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	3.69e-05	0.000459	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	3.49e-05	0.000434	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.42e-05	0.000425	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AGT—dilated cardiomyopathy	3.34e-05	0.000415	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GPX1—dilated cardiomyopathy	3.32e-05	0.000413	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	3.31e-05	0.000412	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	3.24e-05	0.000403	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CD36—dilated cardiomyopathy	3.24e-05	0.000403	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.16e-05	0.000393	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.16e-05	0.000393	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	3.12e-05	0.000387	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RAC1—dilated cardiomyopathy	3.09e-05	0.000384	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	3.05e-05	0.000379	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.01e-05	0.000374	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.01e-05	0.000374	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AGT—dilated cardiomyopathy	2.95e-05	0.000367	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—RAF1—dilated cardiomyopathy	2.93e-05	0.000364	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AGT—dilated cardiomyopathy	2.92e-05	0.000362	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—RAF1—dilated cardiomyopathy	2.87e-05	0.000356	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—dilated cardiomyopathy	2.84e-05	0.000353	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	2.82e-05	0.00035	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.81e-05	0.000349	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GPX1—dilated cardiomyopathy	2.77e-05	0.000345	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.76e-05	0.000344	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.75e-05	0.000342	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CD36—dilated cardiomyopathy	2.7e-05	0.000336	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.69e-05	0.000335	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.67e-05	0.000331	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.64e-05	0.000328	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—RAF1—dilated cardiomyopathy	2.62e-05	0.000326	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.5e-05	0.000311	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.48e-05	0.000308	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AGT—dilated cardiomyopathy	2.43e-05	0.000303	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.42e-05	0.000301	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.39e-05	0.000297	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.37e-05	0.000294	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.37e-05	0.000294	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.35e-05	0.000293	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.3e-05	0.000285	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.28e-05	0.000284	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.25e-05	0.00028	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.2e-05	0.000274	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.19e-05	0.000273	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.15e-05	0.000267	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GPX1—dilated cardiomyopathy	2.14e-05	0.000266	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.13e-05	0.000265	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.13e-05	0.000265	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.13e-05	0.000265	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CD36—dilated cardiomyopathy	2.09e-05	0.000259	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RAF1—dilated cardiomyopathy	2.05e-05	0.000255	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—dilated cardiomyopathy	2.01e-05	0.00025	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.98e-05	0.000246	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.95e-05	0.000243	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.94e-05	0.000241	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.93e-05	0.00024	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RAC1—dilated cardiomyopathy	1.91e-05	0.000238	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GPX1—dilated cardiomyopathy	1.91e-05	0.000237	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AGT—dilated cardiomyopathy	1.88e-05	0.000234	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CD36—dilated cardiomyopathy	1.86e-05	0.000231	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.83e-05	0.000228	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.82e-05	0.000226	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	1.78e-05	0.000221	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	1.73e-05	0.000216	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.73e-05	0.000215	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AGT—dilated cardiomyopathy	1.67e-05	0.000208	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.66e-05	0.000206	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.61e-05	0.0002	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	1.56e-05	0.000194	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	1.56e-05	0.000194	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	1.52e-05	0.000189	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	1.51e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.51e-05	0.000187	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.48e-05	0.000184	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	1.47e-05	0.000183	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.45e-05	0.000181	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.42e-05	0.000176	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.42e-05	0.000176	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—dilated cardiomyopathy	1.41e-05	0.000175	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	1.37e-05	0.00017	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.34e-05	0.000167	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.3e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AGT—dilated cardiomyopathy	1.28e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.28e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.28e-05	0.000159	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RAF1—dilated cardiomyopathy	1.27e-05	0.000158	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.26e-05	0.000157	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	1.23e-05	0.000153	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	1.2e-05	0.000149	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.18e-05	0.000147	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.15e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.14e-05	0.000142	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.04e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.01e-05	0.000126	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1e-05	0.000125	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.85e-06	0.000123	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CD36—dilated cardiomyopathy	9.77e-06	0.000121	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	9.49e-06	0.000118	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	9.24e-06	0.000115	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RAF1—dilated cardiomyopathy	8.89e-06	0.000111	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.87e-06	0.00011	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AGT—dilated cardiomyopathy	8.8e-06	0.000109	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—dilated cardiomyopathy	8.7e-06	0.000108	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	8.32e-06	0.000103	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	7.65e-06	9.52e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	7.48e-06	9.3e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	7.45e-06	9.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	7.29e-06	9.06e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	6.71e-06	8.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	6.56e-06	8.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	6.48e-06	8.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	6.31e-06	7.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.09e-06	7.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.78e-06	7.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	5.68e-06	7.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.63e-06	7e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.27e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.14e-06	6.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.07e-06	6.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	4.62e-06	5.75e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.51e-06	5.6e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.39e-06	5.46e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.95e-06	4.91e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.48e-06	4.32e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.39e-06	4.21e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.05e-06	3.79e-05	CbGpPWpGaD
